Search research articles
Contact Us
Filters
Showing results (11-20 of 37) with videos related to
Page
of 4
Sort By:
Endocrinology
|
February 1, 1989
Cellular localization of müllerian inhibiting substance in the developing rat ovary
S Ueno, M Takahashi, T F Manganaro, et al.
The West Indian Medical Journal
|
January 27, 2010
Cancer screening and cancer mortality in Nevis, West Indies
A S Felix, G Avery, B Mutetwa, et al.
Endocrinology
|
December 1, 1991
Müllerian inhibiting substance production and cleavage is modulated by gonadotropins and steroids
T Kuroda, M M Lee, R C Ragin, et al.
The West Indian Medical Journal
|
July 12, 2014
Knowledge and Attitudes toward HPV and the HPV Vaccines in The Bahamas
D Halliday, R Butler, D Francis, et al.
Cancer Investigation
|
June 24, 2010
Cleft lip and palate in family members of cancer survivors
E Taioli, C Ragin, L Robertson, et al.
Protein Expression and Purification
|
June 1, 1992
Human müllerian inhibiting substance: enhanced purification imparts biochemical stability and restores antiproliferative effects
R C Ragin, P K Donahoe, M K Kenneally, et al.
Infectious Agents and Cancer
|
February 12, 2009
Leptin levels and leptin receptor polymorphism frequency in healthy populations
Camille C Ragin, Cher Dallal, Michael Okobia, et al.
Endocrinology
|
August 1, 1989
Mullerian inhibiting substance in the adult rat ovary during various stages of the estrous cycle
S Ueno, T Kuroda, D T Maclaughlin, et al.
Genomics
|
January 2, 2016
Ancestral-derived effects on the mutational landscape of laryngeal cancer
Meganathan P Ramakodi, Rob J Kulathinal, Yujin Chung, et al.
Cancer Investigation
|
November 27, 2008
Prevalence of cancer-associated viral infections in healthy afro-Caribbean populations: a review of the literature
C Ragin, R Edwards, D E Heron, et al.
Page
of 4
Search research articles
Search
Showing results (11-20 of 37) with videos related to
Sort By:
Page
of 4
Endocrinology
|
February 1, 1989
Cellular localization of müllerian inhibiting substance in the developing rat ovary
S Ueno, M Takahashi, T F Manganaro, et al.
The West Indian Medical Journal
|
January 27, 2010
Cancer screening and cancer mortality in Nevis, West Indies
A S Felix, G Avery, B Mutetwa, et al.
Endocrinology
|
December 1, 1991
Müllerian inhibiting substance production and cleavage is modulated by gonadotropins and steroids
T Kuroda, M M Lee, R C Ragin, et al.
The West Indian Medical Journal
|
July 12, 2014
Knowledge and Attitudes toward HPV and the HPV Vaccines in The Bahamas
D Halliday, R Butler, D Francis, et al.
Cancer Investigation
|
June 24, 2010
Cleft lip and palate in family members of cancer survivors
E Taioli, C Ragin, L Robertson, et al.
Protein Expression and Purification
|
June 1, 1992
Human müllerian inhibiting substance: enhanced purification imparts biochemical stability and restores antiproliferative effects
R C Ragin, P K Donahoe, M K Kenneally, et al.
Infectious Agents and Cancer
|
February 12, 2009
Leptin levels and leptin receptor polymorphism frequency in healthy populations
Camille C Ragin, Cher Dallal, Michael Okobia, et al.
Endocrinology
|
August 1, 1989
Mullerian inhibiting substance in the adult rat ovary during various stages of the estrous cycle
S Ueno, T Kuroda, D T Maclaughlin, et al.
Genomics
|
January 2, 2016
Ancestral-derived effects on the mutational landscape of laryngeal cancer
Meganathan P Ramakodi, Rob J Kulathinal, Yujin Chung, et al.
Cancer Investigation
|
November 27, 2008
Prevalence of cancer-associated viral infections in healthy afro-Caribbean populations: a review of the literature
C Ragin, R Edwards, D E Heron, et al.
Page
of 4